Product
Intravitreal Ranibizumab
Aliases
Intravitreal Ranibizumab 0.5 mg Injection
3 clinical trials
4 indications
Indication
Diabetic Macular EdemaIndication
Diabetic RetinopathyIndication
UveitisIndication
Macular EdemaClinical trial
A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Macular Edema (Pagoda)Status: Active (not recruiting), Estimated PCD: 2022-09-19
Clinical trial
A Phase III, Multicenter, Randomized Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic RetinopathyStatus: Active (not recruiting), Estimated PCD: 2022-10-03
Clinical trial
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy TrialStatus: Completed, Estimated PCD: 2021-10-27